🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dear #neurosurgery residents and especially cranial-focused fellows: The job market for cranial-dedicated academic positions is usually tight. Stay nimble and keep up with basic spine skills - many early career opportunities require this. CNS AANS

Our upcoming special webinar, "How to Navigate ERAS for the NeuroInterventional Fellowship Match" is 4/2 at 3:00 PM ET. Please send us your questions ahead of time to [email protected]. Register: register.gotowebinar.com/register/84621……

Here is the provocative review of nimodipine use after #SAH that brings us back to the original trials 30+ years ago that led to its widespread adoption. With a clinical trial today against placebo still show any benefit? link.springer.com/article/10.100…

#OnlineFirst: The risks of omitting routine postoperative imaging after insertion of new ventricular shunts in children: a 10-year retrospective cohort study. thejns.org/pediatrics/vie…

This morning, Dr. Langston Holly from UCLA Neurosurgery 🧠 delivered a masterclass on Cervical Spondylotic Myelopathy at Grand Rounds, covering surgical indications, minimally invasive options, and long-term outcomes. Great discussion with our faculty and residents #Neurosurgery

#JNSSpine: Clinical and radiographic comparison of robot-assisted single-position versus traditional dual-position lateral lumbar interbody fusion. thejns.org/spine/view/jou…

#NEUEditorsChoice Embolic Materials' Comparison in Meningeal Artery Embolization for Chronic Subdural Hematomas: Multicenter Propensity Score–Matched Analysis of 1070 Cases bit.ly/4m6VTQR by Salem et al Penn Medicine CNS

#ESOC2025: In a retrospective observational cohort study drawing data from 66 sites, EVT was not associated with a lower level of disability than medical management among patients with M2 occlusion presenting in the 6-24h window poststroke symptom onset. ahajournals.org/doi/10.1161/ST…

Our own Dr. Awad!!

Nuevo test en sangre para el diagnóstico de la Enfermedad de Alzheimer. Buena noticia. Se recomienda su uso con cautela. Preferible por especialistas. Solicitarlo basado en la CLÍNICA. Su mal uso puede confundir a pacientes pensando que tiene "Alzheimer" cuando no es el caso.

Very proud to be part of this work. UAMSneurosurg was one of the national sites for this #LAANTERN study.

To admit or not to admit? @JacuesJLR demonstrates the feasibility of MMA embolization as an outpatient procedure given low post-treatment complications and hospital needs #snis2025 @SNISInfo ESMINT Society CV Section Felipe C. Albuquerque Michael Chen, MD Dr. DiestroKE Matthew Amans

Honored to represent U of Illinois Peoria Neurosurgery Residency at #SNIS2025 with a podium presentation and an ePoster on MMA embolization. Thanks SNIS Info JNIS for such an amazing first day

“The SNIS is a pinnacle of working together. Coming from our unique backgrounds in neurology, neurosurgery and radiology, we create a synergy. The whole is greater than the sum of the parts.” Wise words from Johanna T. Fifi, MD in her President's Address!

Data from a large, multicentre registry show significantly lower sICH and vasospasm rates with aspiration versus stent-retriever thrombectomy, as well as a trend towards higher rates of excellent 90-day mRS outcomes associated with aspiration #SNIS2025 Shahram Majidi, MD SNIS Info

A bit late to the party, but can’t miss #SNIS2025. Dr. David Fiorella shared InspireMD CGuard® Prime stent results, intriguing thought by Adnan H. Siddiqui, MD : is it time to reconsider indications for CEA vs CAS in light of these results?! SNIS Info and YNIS Committee

newsroom.heart.org/news/surgical-…

Unos niños estaban tirando bolas de nieve a la ventana de un autobús y esto hizo el conductor

- Median access-to-reperfusion= 19 min. - Only 5.5% required rescue device #JustZoomIt #OwnTheAnatomy #stroke #thrombectomy #Aspiration #ADAPT

Minimally invasive surgical evacuation (MISE) for intracerebral hemorrhage (ICH) has long been debated. The ENRICH trial has provided strong evidence supporting its efficacy in lobar ICH, leading to improved outcomes. This editorial discusses the challenges and future directions